FIELD: chemistry.
SUBSTANCE: present invention relates to antisense oligonucleotides, modulating expression and/or function of interferon-regulatory factor 8 (IRF8), in particular, by targeted interaction with natural antisense polynucleotides of interferon regulatory factor 8 (IRF8).
EFFECT: present invention also relates to identification of such antisense oligonucleotides and use thereof in treating diseases and disorders associated with expression of IRF8.
32 cl, 1 dwg
Authors
Dates
2017-02-21—Published
2011-01-04—Filed